Comparison |
Alternate Manufacturer Number |
| 3739620 |
NDC Number |
58160082311 | 58160-0819-12 |
Application |
Shingles Vaccine | Shingles Vaccine |
Container Type |
Single-Dose Vial | Single-Dose Vial |
Country of Origin |
Unknown | Unknown |
Dosage Form |
Injection | Injection |
Generic Drug Code |
43989 | 43989 |
Generic Drug Name |
Zoster Vaccine Recombinant, Adjuvanted | Zoster Vaccine Recombinant, Adjuvanted |
Product Dating |
McKesson Acceptable Dating: we will ship >= 180 days | McKesson Acceptable Dating: we will ship >= 180 days |
Storage Requirements |
Requires Refrigeration | Requires Refrigeration |
Strength |
50 mcg / 0.5 mL | 50 mcg / 0.5 mL |
Type |
Intramuscular | Intramuscular |
UNSPSC Code |
51201650 | 51201650 |
User |
Indicated for People 50 Years of Age and Older | Indicated for People 50 Years of Age and Older |
Volume |
0.5 mL | 0.5 mL |
Features and Benefits |
- SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older
- SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox)
- SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 18 years and older who are or will be at increased risk of HZ due to immunodeficiency or immunosuppression caused by known disease or therapy
- SHINGRIX is supplied as 2 components: A single-dose vial of lyophilized gE antigen component (brown cap) and a single-dose vial of adjuvant suspension component (blue-green cap) (packaged without syringes or needles)
- A single dose after reconstitution is 0.5 mL
- Administer 2 doses (0.5 mL each) at 0 and 2 to 6 months
- 10 Doses
|
- SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older
- SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox)
- SHINGRIX is supplied as 2 components: A single-dose vial of lyophilized gE antigen component (brown cap) and a single-dose vial of adjuvant suspension component (blue-green cap) (packaged without syringes or needles)
- A single dose after reconstitution is 0.5 mL
- Administer 2 doses (0.5 mL each) at 0 and 2 to 6 months
- 1 Dose
|